Skip to content

A research study comparing different ways of increasing the dose of NNC0519-0130 in participants with overweight or obesity

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-508940-23-01
Acronym
NN9541-7760
Enrollment
114
Registered
2024-09-15
Start date
2025-02-21
Completion date
2026-01-12
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Austria

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026